MARKET

RVPH

RVPH

Reviva Pharmaceutcls Hldgs Inc
OTCMQB
0.340
0.000
0.00%
Opening 14:17 11/13 EST
OPEN
0.340
PREV CLOSE
0.340
HIGH
0.420
LOW
0.340
VOLUME
586
TURNOVER
230
52 WEEK HIGH
23.20
52 WEEK LOW
0.262
MARKET CAP
4.46M
P/E (TTM)
-0.1471
1D
5D
1M
3M
1Y
5Y
1D
Reviva Pharmaceuticals GAAP EPS of -$0.17 beats by $0.23
Seeking Alpha · 14h ago
Reviva Pharmaceuticals Q3 EPS $(0.17) Beats $(0.29) Estimate
Benzinga · 14h ago
Press Release: Reviva Reports Third Quarter 2026 -2-
Dow Jones · 18h ago
Press Release: Reviva Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Dow Jones · 18h ago
Weekly Report: what happened at RVPH last week (1102-1106)?
Weekly Report · 4d ago
Weekly Report: what happened at RVPH last week (1026-1030)?
Weekly Report · 11/02 09:59
Weekly Report: what happened at RVPH last week (1019-1023)?
Weekly Report · 10/26 09:59
Two new option listings and eleven option delistings on October 19th
TipRanks · 10/19 12:36
More
About RVPH
Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Webull offers Reviva Pharmaceuticals Holdings Inc stock information, including OTCMQB: RVPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPH stock methods without spending real money on the virtual paper trading platform.